239 related articles for article (PubMed ID: 28007765)
1. Changing POU dimerization preferences converts Oct6 into a pluripotency inducer.
Jerabek S; Ng CK; Wu G; Arauzo-Bravo MJ; Kim KP; Esch D; Malik V; Chen Y; Velychko S; MacCarthy CM; Yang X; Cojocaru V; Schöler HR; Jauch R
EMBO Rep; 2017 Feb; 18(2):319-333. PubMed ID: 28007765
[TBL] [Abstract][Full Text] [Related]
2. Pluripotency reprogramming by competent and incompetent POU factors uncovers temporal dependency for Oct4 and Sox2.
Malik V; Glaser LV; Zimmer D; Velychko S; Weng M; Holzner M; Arend M; Chen Y; Srivastava Y; Veerapandian V; Shah Z; Esteban MA; Wang H; Chen J; Schöler HR; Hutchins AP; Meijsing SH; Pott S; Jauch R
Nat Commun; 2019 Aug; 10(1):3477. PubMed ID: 31375664
[TBL] [Abstract][Full Text] [Related]
3. Selective influence of Sox2 on POU transcription factor binding in embryonic and neural stem cells.
Mistri TK; Devasia AG; Chu LT; Ng WP; Halbritter F; Colby D; Martynoga B; Tomlinson SR; Chambers I; Robson P; Wohland T
EMBO Rep; 2015 Sep; 16(9):1177-91. PubMed ID: 26265007
[TBL] [Abstract][Full Text] [Related]
4. Critical POU domain residues confer Oct4 uniqueness in somatic cell reprogramming.
Jin W; Wang L; Zhu F; Tan W; Lin W; Chen D; Sun Q; Xia Z
Sci Rep; 2016 Feb; 6():20818. PubMed ID: 26877091
[TBL] [Abstract][Full Text] [Related]
5. The homeodomain of Oct4 is a dimeric binder of methylated CpG elements.
Tan DS; Cheung SL; Gao Y; Weinbuch M; Hu H; Shi L; Ti SC; Hutchins AP; Cojocaru V; Jauch R
Nucleic Acids Res; 2023 Feb; 51(3):1120-1138. PubMed ID: 36631980
[TBL] [Abstract][Full Text] [Related]
6. Diversity among POU transcription factors in chromatin recognition and cell fate reprogramming.
Malik V; Zimmer D; Jauch R
Cell Mol Life Sci; 2018 May; 75(9):1587-1612. PubMed ID: 29335749
[TBL] [Abstract][Full Text] [Related]
7. Quantitative profiling of selective Sox/POU pairing on hundreds of sequences in parallel by Coop-seq.
Chang YK; Srivastava Y; Hu C; Joyce A; Yang X; Zuo Z; Havranek JJ; Stormo GD; Jauch R
Nucleic Acids Res; 2017 Jan; 45(2):832-845. PubMed ID: 27915232
[TBL] [Abstract][Full Text] [Related]
8. SOX2 co-occupies distal enhancer elements with distinct POU factors in ESCs and NPCs to specify cell state.
Lodato MA; Ng CW; Wamstad JA; Cheng AW; Thai KK; Fraenkel E; Jaenisch R; Boyer LA
PLoS Genet; 2013; 9(2):e1003288. PubMed ID: 23437007
[TBL] [Abstract][Full Text] [Related]
9. Structure-based discovery of NANOG variant with enhanced properties to promote self-renewal and reprogramming of pluripotent stem cells.
Hayashi Y; Caboni L; Das D; Yumoto F; Clayton T; Deller MC; Nguyen P; Farr CL; Chiu HJ; Miller MD; Elsliger MA; Deacon AM; Godzik A; Lesley SA; Tomoda K; Conklin BR; Wilson IA; Yamanaka S; Fletterick RJ
Proc Natl Acad Sci U S A; 2015 Apr; 112(15):4666-71. PubMed ID: 25825768
[TBL] [Abstract][Full Text] [Related]
10. Human Amniocytes Are Receptive to Chemically Induced Reprogramming to Pluripotency.
Hawkins KE; Moschidou D; Faccenda D; Wruck W; Martin-Trujillo A; Hau KL; Ranzoni AM; Sanchez-Freire V; Tommasini F; Eaton S; De Coppi P; Monk D; Campanella M; Thrasher AJ; Adjaye J; Guillot PV
Mol Ther; 2017 Feb; 25(2):427-442. PubMed ID: 28153093
[TBL] [Abstract][Full Text] [Related]
11. Control of myelination in Schwann cells: a Krox20 cis-regulatory element integrates Oct6, Brn2 and Sox10 activities.
Ghislain J; Charnay P
EMBO Rep; 2006 Jan; 7(1):52-8. PubMed ID: 16311519
[TBL] [Abstract][Full Text] [Related]
12. Directed Evolution of an Enhanced POU Reprogramming Factor for Cell Fate Engineering.
Tan DS; Chen Y; Gao Y; Bednarz A; Wei Y; Malik V; Ho DH; Weng M; Ho SY; Srivastava Y; Velychko S; Yang X; Fan L; Kim J; Graumann J; Stormo GD; Braun T; Yan J; Schöler HR; Jauch R
Mol Biol Evol; 2021 Jun; 38(7):2854-2868. PubMed ID: 33720298
[TBL] [Abstract][Full Text] [Related]
13. The Pou5f1/Pou3f-dependent but SoxB-independent regulation of conserved enhancer N2 initiates Sox2 expression during epiblast to neural plate stages in vertebrates.
Iwafuchi-Doi M; Yoshida Y; Onichtchouk D; Leichsenring M; Driever W; Takemoto T; Uchikawa M; Kamachi Y; Kondoh H
Dev Biol; 2011 Apr; 352(2):354-66. PubMed ID: 21185279
[TBL] [Abstract][Full Text] [Related]
14. Permissive epigenomes endow reprogramming competence to transcriptional regulators.
Kim KP; Choi J; Yoon J; Bruder JM; Shin B; Kim J; Arauzo-Bravo MJ; Han D; Wu G; Han DW; Kim J; Cramer P; Schöler HR
Nat Chem Biol; 2021 Jan; 17(1):47-56. PubMed ID: 32807969
[TBL] [Abstract][Full Text] [Related]
15. Cancer-associated missense mutations enhance the pluripotency reprogramming activity of OCT4 and SOX17.
Srivastava Y; Tan DS; Malik V; Weng M; Javed A; Cojocaru V; Wu G; Veerapandian V; Cheung LWT; Jauch R
FEBS J; 2020 Jan; 287(1):122-144. PubMed ID: 31569299
[TBL] [Abstract][Full Text] [Related]
16. Dissecting the role of distinct OCT4-SOX2 heterodimer configurations in pluripotency.
Tapia N; MacCarthy C; Esch D; Gabriele Marthaler A; Tiemann U; Araúzo-Bravo MJ; Jauch R; Cojocaru V; Schöler HR
Sci Rep; 2015 Aug; 5():13533. PubMed ID: 26314899
[TBL] [Abstract][Full Text] [Related]
17. Conversion of Sox17 into a pluripotency reprogramming factor by reengineering its association with Oct4 on DNA.
Jauch R; Aksoy I; Hutchins AP; Ng CK; Tian XF; Chen J; Palasingam P; Robson P; Stanton LW; Kolatkar PR
Stem Cells; 2011 Jun; 29(6):940-51. PubMed ID: 21472822
[TBL] [Abstract][Full Text] [Related]
18. Counteracting activities of OCT4 and KLF4 during reprogramming to pluripotency.
Tiemann U; Marthaler AG; Adachi K; Wu G; Fischedick GU; Araúzo-Bravo MJ; Schöler HR; Tapia N
Stem Cell Reports; 2014 Mar; 2(3):351-65. PubMed ID: 24672757
[TBL] [Abstract][Full Text] [Related]
19. Disruption of OCT4 Ubiquitination Increases OCT4 Protein Stability and ASH2L-B-Mediated H3K4 Methylation Promoting Pluripotency Acquisition.
Li S; Xiao F; Zhang J; Sun X; Wang H; Zeng Y; Hu J; Tang F; Gu J; Zhao Y; Jin Y; Liao B
Stem Cell Reports; 2018 Oct; 11(4):973-987. PubMed ID: 30269953
[TBL] [Abstract][Full Text] [Related]
20. Reactivation of Endogenous Genes and Epigenetic Remodeling Are Barriers for Generating Transgene-Free Induced Pluripotent Stem Cells in Pig.
Choi KH; Park JK; Son D; Hwang JY; Lee DK; Ka H; Park J; Lee CK
PLoS One; 2016; 11(6):e0158046. PubMed ID: 27336671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
